Oxytocin Neurons Key to Social Deficits in Autism
Oxytocin neurons are selectively disrupted in autism, but stimulation restores social behaviors.

Complete the form below to unlock access to ALL audio articles.
Summary
RIKEN neuroscientists found oxytocin-secreting neurons are selectively impaired in an autism mouse model, affecting social behavior. Stimulating these neurons postnatally restored oxytocin levels and improved social traits into adulthood. These findings suggest that targeting oxytocin neurons may offer new therapeutic strategies for autism spectrum disorders.
Key Takeaways
- Oxytocin neurons are disproportionately disrupted in an autism mouse model, affecting social behaviors.
- Stimulating these neurons early in life restored oxytocin expression and social behaviors into adulthood.
- Findings suggest new therapeutic approaches targeting oxytocin signaling could help address autism-related social deficits.
Specific neurons that secrete the neuropeptide oxytocin in the brain are disproportionately disrupted in a mouse model of autism, RIKEN neuroscientists have found1. Artificially stimulating neurons restored social behaviors in these mice. These findings could help to develop new ways to treat autism.
Neurodevelopmental disorders such as autism spectrum disorder have been widely studied, but the molecular mechanisms that underlie them remain largely unknown.
In neurodegenerative diseases such as Parkinson’s disease, certain types of neurons are more likely to accumulate disease-related proteins and have their functions impaired. This phenomenon is known as selective neuronal vulnerability.
Knowing which neurons are most vulnerable helps explain the symptoms of neurodegenerative diseases. It can also guide the development of targeted therapeutic approaches.
Want more breaking news?
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.
Subscribe for FREEBut is not known whether selective neuronal vulnerability also applies to neurodevelopmental disorders such as autism spectrum disorder.
Now, Kazunari Miyamichi of the RIKEN Center for Biosystems Dynamics Research and his colleagues have found that oxytocin-secreting neurons—known for their key role in establishing and maintaining social bonds—are selectively disrupted in a neurodevelopmental disorder model associated with atypical social traits.
They used the valproic-acid mouse model of autism spectrum disorder; such mice exhibit reduced social behaviors as a result of being exposed to the anti-epileptic drug valproic acid in the womb.
Miyamichi and his team found that they also have lower oxytocin levels in the brain region housing parvocellular oxytocin neurons that mediate social reward processes.
Single-cell RNA sequencing revealed that many genes crucial for neural function were expressed differently in these cells compared to control mice and that oxytocin gene expression is significantly reduced.
This came as a surprise to the team. “Given the systemic effects of valproic acid, impacting the entire body of embryos without spatial or cell type specificity, we didn’t expect that certain cell types would be disproportionately affected,” says Miyamichi.
Even more surprising was the finding that stimulating these cells shortly after birth led to a gradual but significant increase in oxytocin expression. It also enhanced social behaviors, with mice displaying more exploratory interactions with other mice. Remarkably, a single activation during the neonatal stage had a lasting effect, restoring gene expression and improving social behaviors into young adulthood.
Together, the findings suggest that the concept of selective neuronal vulnerability is applicable to neurodevelopmental disorders and that stimulating the affected cells could restore their function.
These discoveries could have implications for people, Miyamichi says. “Unraveling this recovery process may offer valuable insights into potential strategies for addressing social deficits in a range of human neurodevelopmental disorders.”
Further clinical investigations are needed to explore this exciting possibility.
Reference: Tsurutani M, Goto T, Hagihara M, Irie S, Miyamichi K. Selective vulnerability of parvocellular oxytocin neurons in social dysfunction. Nat Commun. 2024;15(1):8661. doi: 10.1038/s41467-024-53092-w
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.
This content includes text that has been generated with the assistance of AI. Technology Networks' AI policy can be found here.